Summary
JIRE Chart
JIRE: A Decent Core ETF, But No Proven Edge Over Its Benchmark
JPMorgan International Research Enhanced Equity ETF is an active ETF seeking to outperform the MSCI EAFE Index with similar risk. It closely tracks the benchmark in sector/country allocations, fundamentals, volatility, and historical returns. Despite active management, JIRE's performance edge is minimal, but its cost advantage over EFA supports its use as a core EAFE equity holding.
FMR LLC Bolsters Portfolio with Strategic Acquisition in JPMorgan International Research
On September 30, 2024, FMR LLC (Trades, Portfolio), a prominent investment firm, executed a significant transaction by acquiring 3,127,577 shares of JPMorgan International Research Enhanced Equity ETF (JIRE, Financial). This addition has increased FMR LLC (Trades, Portfolio)'s total holdings in JIRE to 12,172,033 shares, reflecting a trade impact of 0.01% on their portfolio.
JIRE: A Reasonable International Bet In An Unsure Domestic Economy
JPMorgan International Research Enhanced Equity ETF launched as an ETF in June 2022 after operating as a mutual fund. JIRE invests in developed markets, with a focus on financials, industrials, healthcare, and consumer discretionary sectors. The fund has shown resilience against the S&P 500, making it a potential hedge against potential U.S. economic uncertainties.
JPMorgan International Research Enhanced Equity ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 308 | $23,063.04 | $25,448.5 | $2,385.46 | 10.34% |
| BS Barrett Schultz Ashton Thomas Securities LLC | 995 | $63,003 | $82,211.87 | $19,208.87 | 30.49% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 8,339 | $613,244.24 | $687,383.77 | $74,139.53 | 12.09% |
| ME Matthew Ellis Planning Directions Inc | 19,687 | $1.42M | $1.63M | $206,485.55 | 14.54% |
 CliftonLarsonAllen Wealth Advisors CliftonLarsonAllen Wealth Advisors LLC | 713,966 | $47.15M | $59.23M | $12.08M | 25.62% |
JPMorgan International Research Enhanced Equity ETF (JIRE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has JPMorgan International Research Enhanced Equity ETF ever had a stock split?
JPMorgan International Research Enhanced Equity ETF Profile
| ARCA Exchange | US Country |
Overview
The fund is designed to primarily focus on equity securities, actively aiming to outperform the MSCI EAFE Index while maintaining similar risk characteristics, including sector and geographic risks. To achieve its objectives, the fund dedicates at least 80% of its assets to investments in equity securities. Although it primarily focuses on securities within the MSCI EAFE Index, it maintains the flexibility to invest in securities outside of the index. The strategic approach of the fund is to invest in companies located exclusively in developed markets, targeting those that present the best opportunities for growth in line with the fund's risk and return objectives.
Products and Services
- Equity Securities Investment
This forms the core of the fund's investment strategy, with at least 80% of assets allocated to equity securities. The goal here is to tap into the growth potential of public companies, particularly those within the developed markets, aligning with the fund's objectives of outperforming the MSCI EAFE Index.
- MSCI EAFE Index-focused Investments
A significant portion of the fund's investment activities is directed towards securities that are part of the MSCI EAFE Index, leveraging the index as a benchmark for performance comparisons. The fund's strategy involves identifying securities within the index that exhibit the potential for high returns while mirroring the index's risk profile.
- Flexibility in Investment Choices
Beyond the primary focus on the index, the fund has the flexibility to invest in securities not included in the MSCI EAFE Index. This opens up opportunities to explore investments in companies that, while not part of the index, demonstrate strong growth potential and can contribute to the overall performance of the fund.
